A new dual-modality deep learning framework called DHF-DTI combines sequence and graph data with cross-attention fusion and ...
Scientists have discovered that a potential new drug can reverse severe fatty liver disease in animal models by restoring gut ...
The U.S. Food and Drug Administration (FDA) approved 13 drugs in September 2026, spanning first-in-class therapies, ...
Starting in January 2027, U.S. Customs and Border Protection plans to enforce new requirements on international mail ...
ANAVEX®2-73 (blarcamesine) has been evaluated in the Fmr1 knockout mouse model of Fragile X syndrome in three peer-reviewed publications, Scientific Reportsi, the American Journal of Medical ...
The "1+" mechanism has been implemented since November 1, 2023, to facilitate the registration of new drugs used for the ...
The European Medicines Agency (EMA) has recommended the approval of a new drug to treat advanced pancreatic cancer. The drug, ...
LB2501 is an off-the-shelf in vivo CAR-T therapy designed to generate dual-targeting CD19/CD20 CAR-T cells directly within ...
INmune Bio Inc. (Nasdaq: INMB) and Quantum Computing Inc. (Nasdaq: QUBT) today announced a collaboration to apply quantum ...
ASX-listed healthcare companies are advancing new approaches to prostate cancer, spanning imaging, targeted therapies and ...
The Journal of Pharmaceutical Investigation has announced a January 2027 special issue on translational advances in ...
On October 14, 2026, 14 items containing 11 new drug ingredients, which were approved by the Central Social Insurance Medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results